Balance Sheet Components

6 Months Ended

Jun. 30, 2026

Balance Sheet Components [Abstract]

Balance Sheet Components

5. Balance Sheet Components

Prepaid expenses and other current assets as of December 31, 2025 and June 30, 2026 consisted of the following (in thousands):

		As of				As of
		December 31,				June 30,
		2025				2026

Prepaid directors’ and officers’ liability insurance premiums		$	332			$	24
Prepaid drug manufacturing supply costs			6,189				7,601
Other			1,171				2,270
Total		$	7,692			$	9,895

Property and equipment as of December 31, 2025 and June 30, 2026 consisted of the following (in thousands):

		As of				As of
		December 31,				June 30,
		2025				2026

Leasehold improvements		$	65			$	36
Lab equipment			26				26
Furniture and fixtures			47				44
Subtotal			138				106
Less accumulated depreciation			(72	)			(65	)
Net		$	66			$	41

Depreciation expense was immaterial for the six months ended June 30, 2026 and 2025 and is included in general and administrative expenses.

Accounts payable as of December 31, 2025 and June 30, 2026 consisted of the following (in thousands):

		As of				As of
		December 31,				June 30,
		2025				2026

Trade accounts payable		$	301			$	2,167
Credit card liability			82				67
Total		$	383			$	2,234

Accrued liabilities as of December 31, 2025 and June 30, 2026 consisted of the following (in thousands):

		As of				As of
		December 31,				June 30,
		2025				2026

Accrued labor costs		$	329			$	1,000
Accrued drug development costs			753				615
Other			441				521
Total		$	1,523			$	2,136